Herbion (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M))

Herbion is used to help relieve symptoms of common respiratory conditions where mucus accumulation impairs breathing. It is typically considered when a patient needs support for natural clearance of airway secretions.

• Relief of productive cough associated with acute bronchitis.
• Adjunct therapy for upper respiratory tract infections.
• Management of chronic bronchitis symptoms.
• Supportive care for mucus‑related cough in children over the age recommended by local regulations.
• Use during seasonal colds to facilitate expectoration.

Side effects reported with ivy leaf extract are generally mild, but users should be aware of both common and less frequent reactions.

Common

• Mild gastrointestinal discomfort such as nausea or stomach upset.
• Transient taste alteration or a bitter after‑taste.
• Mild skin irritation or rash at the oral mucosa.
• Dizziness or light‑headedness, especially when standing quickly.

Serious

• Allergic reactions including swelling of the face, lips, or throat.
• Severe skin rash or hives (urticaria).
• Bronchospasm or difficulty breathing in highly sensitive individuals.
• Hepatic enzyme elevation reported in isolated cases.
• Persistent vomiting or diarrhea leading to dehydration.

Before using Herbion, consider the following safety points to minimize risk.

• Verify that the product is appropriate for the age group indicated on the label.
• Avoid use in individuals with known hypersensitivity to ivy (Hedera) or any component of the formulation.
• Consult a healthcare professional if you are pregnant, planning to become pregnant, or breastfeeding.
• Use caution in patients with chronic liver disease or severe gastrointestinal disorders.
• Discontinue use and seek medical advice if any signs of an allergic reaction appear.
• Do not exceed the recommended daily dose indicated on the packaging.

Herbion may interact with certain medicines; awareness helps prevent adverse effects.

Avoid

• Concurrent use with other strong expectorants or mucolytics without professional guidance.
• Combining with monoamine oxidase inhibitors (MAOIs) due to limited safety data.

Use with caution

• Antihistamines or bronchodilators, as additive effects on airway tone may occur.
• Anticoagulant therapy (e.g., warfarin) because herbal extracts can influence bleeding risk.
• Herbal supplements that also contain ivy or similar expectorant compounds.
• Medications metabolized by the liver enzymes CYP450, pending further evidence.